Stay updated with breaking news from Benzinga Pro. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Nvidia's fundamentals continue to strengthen amid the AI explosion and the stock is likely to head to stratospheric levels.
The chipmaker reported first-quarter earnings and revenue well above lofty expectations and gave an upbeat quarterly revenue outlook.
Cytokinetics shares are trading lower by 15.8% during Thursday's session. The company announced the pricing of a public offering of 9,803,922 shares.